A detailed history of Kornitzer Capital Management Inc transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 804,760 shares of CDMO stock, worth $5.39 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
804,760
Previous 804,760 -0.0%
Holding current value
$5.39 Million
Previous $5.23 Million 3.08%
% of portfolio
0.1%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

BUY
$9.4 - $14.04 $228,467 - $341,242
24,305 Added 3.11%
804,760 $7.6 Million
Q2 2023

Aug 01, 2023

BUY
$12.96 - $20.93 $1.27 Million - $2.05 Million
97,945 Added 14.35%
780,455 $10.9 Million
Q1 2023

May 09, 2023

BUY
$13.48 - $18.79 $1.01 Million - $1.41 Million
75,065 Added 12.36%
682,510 $12.8 Million
Q4 2022

Feb 02, 2023

SELL
$12.61 - $18.74 $2.02 Million - $3 Million
-160,267 Reduced 20.88%
607,445 $8.36 Million
Q3 2022

Nov 03, 2022

SELL
$15.33 - $20.36 $5,365 - $7,126
-350 Reduced 0.05%
767,712 $14.7 Million
Q2 2022

Aug 03, 2022

BUY
$11.63 - $21.55 $1.08 Million - $2 Million
92,985 Added 13.77%
768,062 $11.7 Million
Q1 2022

Apr 27, 2022

BUY
$16.63 - $27.73 $109,242 - $182,158
6,569 Added 0.98%
675,077 $13.8 Million
Q4 2021

Feb 01, 2022

BUY
$20.7 - $34.18 $230,287 - $380,252
11,125 Added 1.69%
668,508 $19.5 Million
Q3 2021

Nov 03, 2021

SELL
$19.05 - $28.32 $1.14 Million - $1.7 Million
-60,000 Reduced 8.36%
657,383 $14.2 Million
Q2 2021

Jul 30, 2021

SELL
$18.93 - $25.65 $5.21 Million - $7.06 Million
-275,160 Reduced 27.72%
717,383 $18.4 Million
Q1 2021

Apr 30, 2021

SELL
$11.86 - $21.77 $506,623 - $929,949
-42,717 Reduced 4.13%
992,543 $18.1 Million
Q4 2020

Jan 29, 2021

BUY
$7.25 - $11.76 $7.51 Million - $12.2 Million
1,035,260 New
1,035,260 $11.9 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $417M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.